Cure Models as a Useful Statistical Tool for Analyzing Survival von OTHUS, Megan, BARLOGIE, Bart, LEBLANC, Michael L, CROWLEY, John J

Volltext

Sex Differences in Risk of Severe Adverse Events in Patients Receiving Immunotherapy, Targeted Therapy, or Chemotherapy in Cancer Clinical Trials von Unger, Joseph M, Vaidya, Riha, Albain, Kathy S, LeBlanc, Michael, Minasian, Lori M, Gotay, Carolyn C, Henry, N Lynn, Fisch, Michael J, Lee, Shing M, Blanke, Charles D, Hershman, Dawn L

Volltext

Assessing chemotherapy dosing strategies in a spatial cell culture model von Deb, Dhruba, Zhu, Shu, LeBlanc, Michael J, Danino, Tal

Volltext

Continued Risk of Relapse Independent of Treatment Modality in Limited-Stage Diffuse Large B-Cell Lymphoma: Final and Long-Term Analysis of Southwest Oncology Group Study S8736 von Stephens, Deborah M, Li, Hongli, LeBlanc, Michael L, Puvvada, Soham D, Persky, Daniel, Friedberg, Jonathan W, Smith, Sonali M

Volltext

Association between Body Mass Index and Cancer Survival in a Pooled Analysis of 22 Clinical Trials von Greenlee, Heather, Unger, Joseph M, LeBlanc, Michael, Ramsey, Scott, Hershman, Dawn L

Volltext

Positron Emission Tomography-Directed Therapy for Patients With Limited-Stage Diffuse Large B-Cell Lymphoma: Results of Intergroup National Clinical Trials Network Study S1001 von Persky, Daniel O, Li, Hongli, Stephens, Deborah M, Park, Steven I, Bartlett, Nancy L, Swinnen, Lode J, Barr, Paul M, Winegarden, 3rd, Jerome D, Constine, Louis S, Fitzgerald, Thomas J, Leonard, John P, Kahl, Brad S, LeBlanc, Michael L, Song, Joo Y, Fisher, Richard I, Rimsza, Lisa M, Smith, Sonali M, Miller, Thomas P, Friedberg, Jonathan W

Volltext

Estimating individualized treatment rules by optimizing the adjusted probability of a longer survival von He, Qijia, Zhang, Shixiao, LeBlanc, Michael L, Zhao, Ying-Qi

Volltext

Biomarker-driven therapies for previously treated squamous non-small-cell lung cancer (Lung-MAP SWOG S1400): a biomarker-driven master protocol von Redman, Mary W, Papadimitrakopoulou, Vassiliki A, Minichiello, Katherine, Hirsch, Fred R, Mack, Philip C, Schwartz, Lawrence H, Vokes, Everett, Ramalingam, Suresh, Leighl, Natasha, Bradley, Jeff, Miao, Jieling, Moon, James, Highleyman, Louise, Miwa, Crystal, LeBlanc, Michael L, Malik, Shakun, Miller, Vincent A, Sigal, Ellen V, Adam, Stacey, Wholley, David, Sigman, Caroline, Smolich, Beverly, Blanke, Charles D, Kelly, Karen, Gandara, David R, Herbst, Roy S

Volltext

Comparison of Survival Outcomes Among Cancer Patients Treated In and Out of Clinical Trials von UNGER, Joseph M, BARLOW, William E, MARTIN, Diane P, RAMSEY, Scott D, LEBLANC, Michael, ETZIONI, Ruth, HERSHMAN, Dawn L

Volltext

US Intergroup Trial of Response-Adapted Therapy for Stage III to IV Hodgkin Lymphoma Using Early Interim Fluorodeoxyglucose-Positron Emission Tomography Imaging: Southwest Oncology... von Press, Oliver W, Li, Hongli, Schöder, Heiko, Straus, David J, Moskowitz, Craig H, LeBlanc, Michael, Rimsza, Lisa M, Bartlett, Nancy L, Evens, Andrew M, Mittra, Erik S, LaCasce, Ann S, Sweetenham, John W, Barr, Paul M, Fanale, Michelle A, Knopp, Michael V, Noy, Ariela, Hsi, Eric D, Cook, James R, Lechowicz, Mary Jo, Gascoyne, Randy D, Leonard, John P, Kahl, Brad S, Cheson, Bruce D, Fisher, Richard I, Friedberg, Jonathan W

Volltext

Risk prediction using genome-wide association studies von Kooperberg, Charles, LeBlanc, Michael, Obenchain, Valerie

Volltext

Portevin-Le Chatelier mechanism in face-centered-cubic metallic alloys from low to high entropy von Tsai, Che-Wei, Lee, Chi, Lin, Po-Ting, Xie, Xie, Chen, Shuying, Carroll, Robert, LeBlanc, Michael, Brinkman, Braden A.W., Liaw, Peter K., Dahmen, Karin A., Yeh, Jien-Wei

Volltext

Experiments and Model for Serration Statistics in Low-Entropy, Medium-Entropy and High-Entropy Alloys von Carroll, Robert, Lee, Chi, Tsai, Che-Wei, Yeh, Jien-Wei, Antonaglia, James, Brinkman, Braden A. W., LeBlanc, Michael, Xie, Xie, Chen, Shuying, Liaw, Peter K., Dahmen, Karin A.

Volltext

Long-Term Effects of Finasteride on Prostate Cancer Mortality von Goodman, Phyllis J, Tangen, Catherine M, Darke, Amy K, Lucia, M. Scott, Ford, Leslie G, Minasian, Lori M, Parnes, Howard L, LeBlanc, Michael L, Thompson, Ian M

Volltext

Designing precision medicine trials to yield a greater population impact von Zhao, Ying‐Qi, LeBlanc, Michael L.

Volltext

Lung Master Protocol (Lung-MAP)-A Biomarker-Driven Protocol for Accelerating Development of Therapies for Squamous Cell Lung Cancer: SWOG S1400 von Herbst, Roy S, Gandara, David R, Hirsch, Fred R, Redman, Mary W, LeBlanc, Michael, Mack, Philip C, Schwartz, Lawrence H, Vokes, Everett, Ramalingam, Suresh S, Bradley, Jeffrey D, Sparks, Dana, Zhou, Yang, Miwa, Crystal, Miller, Vincent A, Yelensky, Roman, Li, Yali, Allen, Jeff D, Sigal, Ellen V, Wholley, David, Sigman, Caroline C, Blumenthal, Gideon M, Malik, Shakun, Kelloff, Gary J, Abrams, Jeffrey S, Blanke, Charles D, Papadimitrakopoulou, Vassiliki A

Volltext

Restricted survival benefit with right‐censored data von Zhang, Shixiao, LeBlanc, Michael L., Zhao, Ying‐Qi

Volltext

Randomized Phase II Designs von Rubinstein, Larry, Crowley, John, Ivy, Percy, Leblanc, Michael, Sargent, Dan

Volltext

Reply to E. Hawkes et al von Persky, Daniel O, Smith, Sonali M, LeBlanc, Michael L, Friedberg, Jonathan W

Volltext

Extranodal presentation in limited-stage diffuse large Bcell lymphoma as a prognostic marker in three SWOG trials S0014, S0313 and S1001 von Stephens, Deborah M., Li, Hongli, Constine, Louis S., Fitzgerald, Thomas J., Leonard, John P., Kahl, Brad S., Song, Joo Y., LeBlanc, Michael L., Smith, Sonali M., Persky, Daniel O., Friedberg, Jonathan W.

Volltext